MEAD JOHNSON & COMPANY
Patent Owner
Stats
- 3 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Apr 29, 2010 most recent publication
Details
- 3 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,158 Total Citation Count
- Apr 02, 1975 Earliest Filing
- 81 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
4617291 Angiotensin-converting enzyme inhibiting dipeptide derivativesExpiredMay 14, 82Oct 14, 86[A61K, C07C, C07K]
4581357 Antipsychotic 5-fluoro-pyrimidin-2-yl piperazine compoundExpiredMar 26, 84Apr 08, 86[A61K, C07D]
4547358 Sustained release tablet containing at least 95 percent theophyllineExpiredJun 04, 84Oct 15, 85[A61K]
4524206 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivativesExpiredSep 12, 83Jun 18, 85[C07D]
4495352 Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanolsExpiredDec 03, 81Jan 22, 85[A61K, C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.